Arbutus Biopharma Aktie
4,19
EUR
-0,31
EUR
-6,89
%
4,80
USD
-0,35
USD
-6,71
%
Arbutus Biopharma jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Arbutus Biopharma Aktie Analyse
| 16.10.18 | Arbutus Biopharma Buy | B. Riley FBR | |
| 12.10.18 | Arbutus Biopharma Buy | Chardan Capital Markets | |
| 19.03.18 | Arbutus Biopharma Buy | Chardan Capital Markets | |
| 05.01.18 | Arbutus Biopharma Buy | B. Riley FBR, Inc. | |
| 04.04.17 | Arbutus Biopharma Buy | Chardan Capital Markets | |
| 01.02.17 | Arbutus Biopharma Outperform | Wedbush Morgan Securities Inc. | |
| 30.11.16 | Arbutus Biopharma Buy | Chardan Capital Markets | |
| 06.11.15 | Arbutus Biopharma Outperform | RBC Capital Markets | |
|
Werbung
|
|||
Werbung
Werbung